Eric Victory


Aurinia Pharmaceuticals

Eric is VP, Global Strategic Marketing at Aurinia Pharmaceuticals in Rockville, MD. Previously, Eric worked at AstraZeneca’s MedImmune unit as VP, Partnering & Strategy – Head for Cardiovascular, Metabolic, & Infectious Disease, leading licensing activities for two of the company’s therapeutic areas. In this role, Eric successfully closed the acquisitions of Spirogen and Amplimmune, brought on Sanofi Pasteur as a partner in developing MedImmune’s MEDI8897 (nirsevimab) next-generation RSV antibody, and led negotiations for multiple other key agreements across the pipeline. Before that he managed MedImmune’s US Government pandemic influenza contracting, and held other roles in business development and marketing. Eric served over 5 years as a commissioned officer in the US Navy Nuclear Propulsion Program, and he holds bachelors degrees in physics and political science from Stanford University, and an MBA from Northwestern University’s Kellogg School of Management.